The Fate of Beta-Cells in Type 2 Diabetes and the Possible Role of Pharmacological Interventions
- 1 January 2006
- journal article
- Published by Raiya Academic International LLC in The Review of Diabetic Studies
- Vol. 3 (4) , 208
Abstract
This article gives an overview of two recent trials investigating rosiglitazone, a thiazolidinedione, in its potential to prevent type 2 diabetes (T2D) and in its effectiveness in monotherapy. Thiazolidinediones are among the most important developments of recent years for combating T2D and therefore worth to revisit. The possible influence of thiazolidines in improving beta-cell function is discussed as well as the potential effects on insulin resistance and obesity. Novel, incretin-based therapies (GLP-1 analogues and DPP-4 inhibitors) and their effects on beta-cell function and beta-cell mass are also summarized and critically evaluated.Keywords
This publication has 45 references indexed in Scilit:
- Finding New Treatments for Diabetes — How Many, How Fast . . . How Good?New England Journal of Medicine, 2007
- Exenatide in type 2 diabetes: treatment effects in clinical studies and animal study dataInternational Journal Of Clinical Practice, 2006
- Glucose lowering and diabetes prevention: are they the same?The Lancet, 2006
- The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)Diabetologia, 2006
- Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion?Diabetes & Metabolism, 2005
- The Diabetes Prevention Program (DPP)Diabetes Care, 2002
- Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trialThe Lancet, 2002
- Assessing the potential for α-glucosidase inhibitors in prediabetic statesDiabetes Research and Clinical Practice, 1998
- U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.1995
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995